Cargando…
Recent Developments of Systemic Chemotherapy for Gastric Cancer
Gastric cancer (GC) is a molecularly heterogeneous disease. Its molecular background, epidemiology, and standard of care are quite different between Eastern and Western countries. Many efforts have been made in developing more effective surgeries and adjuvant chemotherapies for resectable GC in each...
Autores principales: | Arai, Hiroyuki, Nakajima, Takako Eguchi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281322/ https://www.ncbi.nlm.nih.gov/pubmed/32354119 http://dx.doi.org/10.3390/cancers12051100 |
Ejemplares similares
-
Fluoropyrimidine with or without platinum as first-line chemotherapy in patients with advanced gastric cancer and severe peritoneal metastasis: a multicenter retrospective study
por: Arai, Hiroyuki, et al.
Publicado: (2019) -
Recent Advances in Intra-peritoneal Chemotherapy for Gastric Cancer
por: Chia, Daryl K.A., et al.
Publicado: (2020) -
Profile of trifluridine/tipiracil hydrochloride in the treatment of metastatic colorectal cancer: efficacy, safety, and place in therapy
por: Sunakawa, Yu, et al.
Publicado: (2017) -
Recent updates in perioperative chemotherapy and recurrence pattern of gastric cancer
por: Kanaji, Shingo, et al.
Publicado: (2018) -
Recent developments in topoisomerase-targeted cancer chemotherapy
por: Hevener, KirkE., et al.
Publicado: (2018)